Here are the financial returns on generative AI investments at health systems, according to a Jan. 29 Deloitte report that surveyed 121 healthcare C-suite executives across the globe:
1. Too early to measure/haven’t measured: 37%
2. Moderate return on investment: 33%
3. Low return on investment: 12%
4. Significant return on investment: 10%
5. Did not invest enough to assess return: 5%
6. Not sure/can’t say: 2%
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
